Skip to main content

박예완 교수

Yae-won Park

경희대학교 소화기내과 · 의학

연구실 소개

박예완 교수의 연구실은 간질환 분야에서 다학제적 접근을 통해 실생활 임상 현장의 문제를 해결하고자 합니다. 주요 연구 분야로는 간세포질환, 특히 간세포암과 지방간 관련 질환의 발생 기전과 예후 인자 규명, 항바이러스 치료 후 예후 평가 등이 포함됩니다. 특히 항바이러스 치료 후 바이러스 표지항원 소실 이후의 간세포암 발생 위험, 모유 수유와 간지방증의 관계 등 실생활에서의 임상적 의미를 고려한 연구를 지속하고 있습니다. 최근에는 대사성 dyslipidemia와 헬리코박터 파일로리 감염의 연관성 등 전신적 대사질환과의 연관성 연구도 확장하고 있습니다.

간세포암지방간항바이러스 치료예후 인자대사성질환

연구 현황

논문 수
40
총 인용 수
303
최근 5년 논문
28
주요 분야
의학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
28총합
2022
2023
2024
2025
2026
5개년 연도별 피인용 수
146총합
20222023202420252026

주요 논문

15
1
논문|인용수 46·2021
Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea
Myung Ji Goh, Joo Hyun Oh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
SJR Q1Liver CancerOA

BACKGROUND: Lenvatinib has been recently approved as a first-line treatment option for patients with unresectable hepatocellular carcinoma (HCC) in Korea. We aimed to study the efficacy and safety of lenvatinib therapy in a real-world practice and to find prognostic factors related to survival and disease progression. METHODS: A hospital-based retrospective study was conducted on 111 consecutive patients who had unresectable HCC and were treated with lenvatinib at Samsung Medical Center from Oct

HepatologyMedicine
2
논문|인용수 37·2020
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study
Minseok Albert Kim, Seung Up Kim, Dong Hyun Sinn, Jeong Won Jang, Young‐Suk Lim, Sang Hoon Ahn, Jae‐Jun Shim, Yeon Seok Seo, Yang Hyun Baek, Sang Gyune Kim, Young Seok Kim, Ji Hoon Kim
SJR Q1GutOA

OBJECTIVE: Direct comparison of the clinical outcomes between nucleos(t)ide analogue (NA) discontinuation versus NA continuation has not been performed in patients with chronic hepatitis B who achieved HBsAg-seroclearance. Whether NA discontinuation was as safe as NA continuation after NA-induced surface antigen of HBV (HBsAg) seroclearance was investigated in the present study. DESIGNS: This multicentre study included 276 patients from 16 hospitals in Korea who achieved NA-induced HBsAg serocle

EpidemiologyMedicine
3
논문|인용수 30·2024
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
Yewan Park, Jooyi Jung, Seungbong Han, Gi‐Ae Kim
SJR Q1Alimentary Pharmacology & TherapeuticsOA

BACKGROUND: The new nomenclature of metabolic dysfunction-associated steatotic liver disease (MASLD) substituting nonalcoholic fatty liver disease was proposed along with a new category of MASLD with increased alcohol intake (MetALD). AIMS: We aimed to explore the cancer risk by MASLD and MetALD. METHODS: This nationwide cohort study included 3,596,709 participants who underwent a health check-up in 2011 in South Korea. Steatotic liver disease (SLD) was defined as a fatty liver index ≥30. Partic

EpidemiologyMedicine
4
논문|인용수 25·2021
Eradication of Helicobacter pylori infection decreases risk for dyslipidemia: A cohort study
Yewan Park, Tae Jun Kim, Hyuk Lee, Heejin Yoo, Insuk Sohn, Yang Won Min, Byung‐Hoon Min, Jun Haeng Lee, Poong‐Lyul Rhee, Jae J. Kim
SJR Q1Helicobacter

BACKGROUND: Previous studies have suggested a relationship between Helicobacter pylori infection and dyslipidemia; however, large-scale longitudinal studies have not elucidated this association. This study assessed the longitudinal effects of H. pylori infection and eradication on lipid profiles in a large cohort. METHODS: This cohort study included 2,626 adults without dyslipidemia at baseline, who participated in a repeated, regular health-screening examination, which included upper gastrointe

SurgeryMedicine
5
논문|인용수 23·2021
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort Study
Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak
SJR Q1Hepatology

BACKGROUND AND AIMS: Breastfeeding has multiple effects on maternal health outcomes. However, the effect of breastfeeding on NAFLD in parous women remains unclear. APPROACH AND RESULTS: A total of 6,893 Korean parous women aged 30-50 years who participated in the Korean National Health and Nutrition Examination Survey were assessed for the association between breastfeeding and NAFLD. Duration of lactation was calculated by dividing the total lactation period by the number of breastfed children.

EpidemiologyMedicine
6
논문|인용수 18·2021
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
Yewan Park, Jeong‐Hoon Lee, Dong Hyun Sinn, Jun Yong Park, Minseok Albert Kim, Yoon Jun Kim, Jung‐Hwan Yoon, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik
SJR Q1Clinical and Translational GastroenterologyOA

INTRODUCTION: Hepatocellular carcinoma (HCC) can develop among chronic hepatitis B patients after hepatitis B surface antigen (HBsAg) seroclearance. However, whether HCC risk after HBsAg seroclearance differs between antiviral therapy (AVT)-induced or spontaneous seroclearance cases and ways to identify at-risk populations remain unclear. METHODS: A retrospective cohort of 1,200 adult chronic hepatitis B patients who achieved HBsAg seroclearance (median age: 56 years; 824 men; 165 with cirrhosis

EpidemiologyMedicine
7
논문|인용수 16·2023
Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum‐Youn Gwak
SJR Q2BMC GastroenterologyOA

BACKGROUND: No randomized controlled trials have been completed to see whether statin can decrease hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. We used large-scale, population-based, observational data to emulate a target trial with two groups, statin user and statin non-user. METHODS: Among 1,379,708 nonunique individuals from the Korean National Health Insurance Service data, 2,915 CHB patients with serum cholesterol level of 200 mg/dL or higher who started statin

Cancer ResearchBiochemistry, Genetics and Molecular Biology
8
논문|인용수 16·2022
Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
Dong Hyun Sinn, Danbee Kang, Sung C. Choi, Yun Soo Hong, Di Zhao, Eliseo Güallar, Yewan Park, Juhee Cho, Geum‐Youn Gwak
SJR Q1Clinical Gastroenterology and Hepatology
EpidemiologyMedicine
9
논문|인용수 14·2023
Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study
Yewan Park, Dong Hyun Sinn, Kyunga Kim, Geum‐Youn Gwak
SJR Q1Scientific ReportsOA

It is unclear if various types and domains of exercise have an identical effect on non-alcoholic fatty liver disease (NAFLD). Thus, this study aimed to investigate associations of different physical activity domains and muscle strength exercise with NAFLD using a nation-wide cohort database. Adults aged 20-79 years who participated in the Korean National Health and Nutrition Examination Survey between 2014 and 2018 were analyzed. Hepatic steatosis index was used to identify NAFLD. Physical activ

EpidemiologyMedicine
10
논문|인용수 10·2023
Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
Dong Hyun Sinn, Danbee Kang, Eliseo Güallar, Sung C. Choi, Yun Soo Hong, Yewan Park, Juhee Cho, Geum‐Youn Gwak
SJR Q1PLoS ONEOA

OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is potentially reversible. However, whether improvement of NAFLD leads to clinical benefits remains uncertain. We investigated the association between regression of NAFLD and the risk of incident diabetes in a longitudinal way. METHODS: A cohort of 11,260 adults who had NAFLD at in an initial exam, had the second evaluation for NAFLD status at 1~2 years from an initial exam were followed up for incident diabetes from 2001 and 2016. NAFLD was d

EpidemiologyMedicine
11
논문|인용수 9·2023
Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study
Jong-In Chang, Jung Hee Kim, Dong Hyun Sinn, Ju‐Yeon Cho, Kwang Min Kim, Joo Hyun Oh, Yewan Park, Won Sohn, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik
SJR Q1Gut and LiverOA

URS demonstrated good performance in predicting a UDCA treatment response in Asian PBC patients. In addition, the risk of liver-related events differed according to the URS for the PBC stage. Thus, URS can be used to predict the response and clinical outcome in patients with PBC.

HepatologyMedicine
12
논문|인용수 8·2022
The association of non‐alcoholic fatty liver disease between parents and adolescent children
Yewan Park, Dong Hyun Sinn, Kyunga Kim, Geum‐Youn Gwak
SJR Q1Alimentary Pharmacology & Therapeutics

BACKGROUND: Data reporting the heritability of non-alcoholic fatty liver disease (NAFLD) are highly variable. AIMS: To investigate the association of NAFLD between parents and their adolescent children using a nationwide, population-based cohort. METHODS: We analysed 1737 families with both parents and adolescent children aged 12-18 who participated in Korean National Health and Nutrition Examination Surveys (KNHANES) between 2010 and 2019. NAFLD was defined by body mass index and elevated alani

EpidemiologyMedicine
13
논문|인용수 7·2024
Effect of renin-angiotensin system inhibitor in incident cancer among chronic hepatitis B patients: An emulated target trial using a nationwide cohort
Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum‐Youn Gwak
SJR Q2Journal of the Renin-Angiotensin-Aldosterone SystemOA

Background Although the renin-angiotensin system (RAS) has been reported to be associated with cancer development, the anticancer effects of RAS inhibitors (RASi) remain controversial. Objectives This study aimed to investigate the effect of RASi use on cancer incidence in chronic hepatitis B (CHB) patients. Design We designed a series of pragmatic trials for each week and followed the patients until the cancer diagnosis, death, or end of follow-up. Methods We analyzed CHB patients aged 40–84 ye

Cardiology and Cardiovascular MedicineMedicine
14
논문|인용수 4·2023
Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum‐Youn Gwak
SJR Q1World Journal of GastroenterologyOA

LSM lowered the risk of HCC and mortality in patients with CHB. Thus, active LSM, particularly alcohol abstinence and smoking cessation, should be encouraged in patients with CHB.

EpidemiologyMedicine
15
논문|인용수 1·2025
Association between maternal chronic hepatitis B virus infection and the neurodevelopment of children: A comprehensive Korean cohort study
Yewan Park, Jihye Heo, Danbee Kang, Geum‐Youn Gwak
SJR Q1Preventive Medicine ReportsOA

Objective: Previous studies have indicated a potential association between maternal Hepatitis B virus (HBV) infection and impaired neurodevelopment in offspring. This study aimed to evaluate the relationship between maternal HBV infection and neurodevelopmental disorders (NDD) in children. Methods: A retrospective cohort study was conducted utilizing data from the Korean National Health Insurance Service database, encompassing live births from 2005 to 2019. The cohort comprised children born to

EpidemiologyMedicine

대표 연구 분야

EpidemiologyHepatologySurgeryCancer ResearchCardiology and Cardiovascular MedicinePharmacology

박예완 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.